Filing Flows › Vycor Medical (VYCO) › Q1 2025
Vycor Medical (VYCO) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Vycor Medical (VYCO) reported revenue of $436K for the first quarter 2025 (Q1 2025), +30% from a year earlier and -4% from the quarter before. Operating margin was -2.9%, net loss $39K (8.8% of revenue).
Vycor Medical, Q1 2025: revenue $436K (+30% year over year), operating margin -2.9%, net loss $39K, operating cash flow −$27K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $436K | -4% | +30% |
| Operating profit | −$13K | -166% | — |
| Net earnings | −$39K | — | — |
| Operating cash flow | −$27K | — | — |
What changed
Revenue was $436K in Q1 2025, up 30% year over year and down 4% from the previous quarter. Vycor Medical Inc was the largest line at 96% of revenue. Vycor Medical Inc added $100K year over year (up 31%), 101% of the total change. Nova Vision Inc declined 3%.
Gross margin was 82.2%, down 6.9 points from a year earlier. Operating costs exceeded revenue by $13K, an operating margin of -2.9%. Operating expenses grew 20% against revenue growth of 30%. The fastest-growing cost line was SG&A (+19%). The quarter ended with a net loss of $39K, wider than the previous quarter's $7K loss. Net interest and other expense of $26K was the main reason.
Operating cash flow was −$27K. Non-cash charges added back $15K of depreciation and amortization and $18K of share-based compensation. Working capital and other items used $22K.
Questions
What was Vycor Medical's revenue in the first quarter 2025?
Vycor Medical (VYCO) reported revenue of $436K for the first quarter 2025 (Q1 2025), +30% from a year earlier and -4% from the quarter before.
Was Vycor Medical profitable in the first quarter 2025?
Operating loss was $13K (-2.9% of revenue) and net loss $39K.
Source: Vycor Medical 10-Q on SEC EDGAR.